These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10532517)

  • 1. Transcranial Doppler evaluation of microembolism immediately after direct-current cardioversion for atrial fibrillation in anticoagulated patients.
    Kay R; Chung HK; Wong KS; Li H; Wong A; Woo KS; Sanderson J
    Am J Cardiol; 1999 Oct; 84(8):937-8, A7. PubMed ID: 10532517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does short-term anticoagulation with heparin increase risk for microemboli patients undergoing transesophageal guided electrical cardioversion for atrial fibrillation? A transcranial Doppler ultrasonography study.
    Gokterin O; Uzener N; Ata N; Kudaiberdieva G; Gucuyener D; Ozdemir G; Timuralp B
    Int J Cardiol; 2003 Mar; 88(1):107-12. PubMed ID: 12659996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral microembolism detected by transcranial Doppler during cardiac procedures.
    Stygall J; Kong R; Walker JM; Hardman SM; Harrison MJ; Newman SP
    Stroke; 2000 Oct; 31(10):2508-10. PubMed ID: 11022086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Embolic stroke after unanticoagulated cardioversion despite prior exclusion of atrial thrombi by transoesophageal echocardiography.
    Missault L; Jordaens L; Gheeraert P; Adang L; Clement D
    Eur Heart J; 1994 Sep; 15(9):1279-80. PubMed ID: 7982431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anticoagulation in atrial fibrillation before cardioversion].
    Stellbrink C; Hanrath P
    Dtsch Med Wochenschr; 1999 Apr; 124(13):407. PubMed ID: 10226651
    [No Abstract]   [Full Text] [Related]  

  • 6. Absence of circulating microemboli in patients with atrial fibrillation undergoing electric cardioversion.
    Nabavi DG; Allroggen A; Reinecke H; Kemény V; Droste DW; Breithardt G; Ringelstein EB
    Cerebrovasc Dis; 2001; 11(2):95-9. PubMed ID: 11223660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Oral Anticoagulants in Direct Current Cardioversion for Atrial Fibrillation.
    Femia G; Fetahovic T; Shetty P; Lee A
    Heart Lung Circ; 2018 Jul; 27(7):798-803. PubMed ID: 28802808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating cardioversion outcomes for atrial fibrillation on novel oral anticoagulants versus warfarin: experience at a tertiary referral centre.
    Sharif Z; Srinivas B; Tiedt I; Ryan N; Awadalla M; Sullivan V; Foley DP; Gumbrielle T; McAdam B; Sheahan RG
    Ir J Med Sci; 2017 Aug; 186(3):615-620. PubMed ID: 28233168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New oral anticoagulants versus Warfarin in patients undergoing cardioversion of atrial fibrillation.
    Andò G; Trio O
    Int J Cardiol; 2016 Dec; 225():244-246. PubMed ID: 27736714
    [No Abstract]   [Full Text] [Related]  

  • 10. [Practical experiences with cardioversion].
    Schweitzer F
    Wien Z Inn Med; 1967; 48(7):263-70. PubMed ID: 5620576
    [No Abstract]   [Full Text] [Related]  

  • 11. A new integrated strategy for direct current cardioversion in non-valvular atrial fibrillation patients using short term rivaroxaban administration: The MonaldiVert real life experience.
    Russo V; Di Napoli L; Bianchi V; Tavoletta V; De Vivo S; Cavallaro C; Vecchione F; Rago A; Sarubbi B; Calabrò P; Nigro G; D'Onofrio A
    Int J Cardiol; 2016 Dec; 224():454-455. PubMed ID: 27716588
    [No Abstract]   [Full Text] [Related]  

  • 12. Complications of cardioversion.
    Turner JR; Towers JR
    Lancet; 1965 Sep; 2(7413):612-4. PubMed ID: 4157503
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis.
    Telles-Garcia N; Dahal K; Kocherla C; Lip GYH; Reddy P; Dominic P
    Int J Cardiol; 2018 Oct; 268():143-148. PubMed ID: 30041779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation and anticoagulation.
    Marcus RR; Atwood JE
    Adv Intern Med; 1999; 44():239-65. PubMed ID: 9929711
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thromboembolism following cardioversion of atrial flutter].
    Appel JM; Tuxen CD; Hildebrandt PR
    Ugeskr Laeger; 1999 Aug; 161(31):4409-11. PubMed ID: 10487107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Findings of transoesophageal echocardiogram in appropriately anticoagulated patients with persistent atrial fibrillation prior to planned cardioversion.
    Barysienė J; Žebrauskaitė A; Petrikonytė D; Marinskis G; Aidietienė S; Aidietis A
    BMC Cardiovasc Disord; 2017 Feb; 17(1):67. PubMed ID: 28228120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Termination of paroxysm of atrial fibrillation conversion using oral propafenone after unsuccessful electrical cardioversion].
    Kupriianova OG; Pavlov AV; Vaniev SB; Doshchitsin VL
    Kardiologiia; 2012; 52(4):95-6. PubMed ID: 22839523
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prophylactic administration of anticoagulant therapy in electric cardioversion for atrial fibrillation or atrial flutter].
    Jirmár R; Gregor P
    Cor Vasa; 1993; 35(3):K81-2. PubMed ID: 8348810
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cerebral embolism after electric depolarization of a patient with cardiac fibrillation treated with fibrinolysin].
    Serkina AV; Chernykh RI
    Klin Med (Mosk); 1969 Nov; 47(11):149-50. PubMed ID: 4245165
    [No Abstract]   [Full Text] [Related]  

  • 20. Physician practices regarding anticoagulation and cardioversion of atrial fibrillation.
    Schlicht JR; Davis RC; Naqi K; Cooper W; Rao BV
    Arch Intern Med; 1996 Feb; 156(3):290-4. PubMed ID: 8572839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.